Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

▎药明康德内容团队编辑今天，在2024年欧洲皮肤病和性病学会（EADV）大会上公布的一项开创性研究表明，司美格鲁肽（semaglutide）在治疗肥胖人群的常见慢性皮肤病化脓性汗腺炎（HS）上展现巨大潜力。该研究对2020年6月至2023年3月期间的 ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with ...

来自爱尔兰都柏林圣文森特大学医院的首席研究员Daniel Lyons博士解释说:“我们的研究结果表明，即使是适度剂量的西马鲁肽，也可以在控制HS方面提供实质性的好处。虽然这种药物在促进减肥方面的作用是公认的，但特别令人兴奋的是，它还可能减少HS发作的频率，从而显著改善患者的生活质量。” ...

Semaglutide for obesity was associated with superior weight reduction and glycemic control among patients with obesity and prediabetes.

在2024年拉斯克临床医学研究奖的三位得主中，洛克菲勒大学的科学家Svetlana ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

HealthDay News — For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according ...

A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the ...

When we talk about GLP-1 medications, we're usually focused on weight loss or the drug's side effects (we're looking at you, ...

根据AI大模型测算泰恩康后市走势。短期趋势看，连续2日被主力资金减仓。主力没有控盘。中期趋势方面，上方有一定套牢筹码积压。近期该股获筹码青睐，且集中度渐增。舆情分析来看，目前市场情绪极度悲观。